enGenes teams with Sweetgrass Bio to address North American biologics

Vienna, Austria: – End-to-end bioprocessing specialist CDMO enGenes Biotech is deepening its relationship with North America’s biotech community through its new partnership with the Sweetgrass Bio consultancy.

Sweetgrass Bio, led by Dr. Christy Franco, is a Texas-based consultancy that specializes in working with advanced therapies organizations, CDMOs, and platform technology companies to align manufacturing, quality, and regulatory realities with commercial strategy and execution.

Boosting Manufacturing Readiness

Sweetgrass consulting services are grounded in deep, hands-on experience across the biologics value chain, with Christy Franco’s expertise grounded in her PhD in Bioengineering from Rice University and deep domain expertise across the plasmid DNA value chain.

The collaboration with enGenes and its industry-leading proprietary microbial expression platforms will boost the core Sweetgrass Bio offer of Manufacturing Readiness & Commercial Alignment, taking in capability gap assessments, quality systems, and tech transfer.

To read more, click here